TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'
Go back to TD Cowen Upgrades Pacira Pharmaceuticals (PCRX) to Outperform, 'Anticipate Sentiment Reversal In 2H23'| PACIRA (NASDAQ: PCRX) | Delayed: 23.83 -0.53 (2.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.36 | 52 Week High | $80.25 | |||
| Open | $24.11 | 52 Week Low | $30.25 | |||
| Day High | $24.41 | P/E | N/A | |||
| Day Low | $23.72 | EPS | $-2.08 | |||
| Volume | 402,799 | |||||

